PharmaCyte Biotech, Inc. Quarterly Operating Income (Loss) in USD from Q2 2011 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
PharmaCyte Biotech, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q2 2011 to Q2 2024.
  • PharmaCyte Biotech, Inc. Operating Income (Loss) for the quarter ending July 31, 2024 was -$1.27M, a 38.9% increase year-over-year.
  • PharmaCyte Biotech, Inc. Operating Income (Loss) for the twelve months ending July 31, 2024 was -$7.71M, a 12.6% decline year-over-year.
  • PharmaCyte Biotech, Inc. annual Operating Income (Loss) for 2023 was -$8.52M, a 32% decline from 2022.
  • PharmaCyte Biotech, Inc. annual Operating Income (Loss) for 2022 was -$6.46M, a 47% decline from 2021.
  • PharmaCyte Biotech, Inc. annual Operating Income (Loss) for 2021 was -$4.39M, a 21.2% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$7.71M -$1.27M +$806K +38.9% May 1, 2024 Jul 31, 2024 10-Q 2024-09-17
Q1 2024 -$8.52M -$3.17M -$2.26M -251% Feb 1, 2024 Apr 30, 2024 10-K 2024-08-13
Q4 2023 -$6.26M -$1.87M -$316K -20.3% Nov 1, 2023 Jan 31, 2024 10-Q 2024-03-18
Q3 2023 -$5.94M -$1.41M +$909K +39.2% Aug 1, 2023 Oct 31, 2023 10-Q 2023-12-15
Q2 2023 -$6.85M -$2.08M -$395K -23.5% May 1, 2023 Jul 31, 2023 10-Q 2024-09-17
Q1 2023 -$6.46M -$903K +$604K +40.1% Feb 1, 2023 Apr 30, 2023 10-K 2024-08-13
Q4 2022 -$7.06M -$1.55M -$697K -81.4% Nov 1, 2022 Jan 31, 2023 10-Q 2024-03-18
Q3 2022 -$6.36M -$2.32M -$1.31M -131% Aug 1, 2022 Oct 31, 2022 10-Q 2023-12-15
Q2 2022 -$5.05M -$1.68M -$657K -64.2% May 1, 2022 Jul 31, 2022 10-Q 2023-09-18
Q1 2022 -$4.39M -$1.51M -$473K -45.7% Feb 1, 2022 Apr 30, 2022 10-K 2023-07-31
Q4 2021 -$3.92M -$856K -$99.3K -13.1% Nov 1, 2021 Jan 31, 2022 10-Q 2023-03-16
Q3 2021 -$3.82M -$1M -$55.3K -5.83% Aug 1, 2021 Oct 31, 2021 10-Q 2022-12-14
Q2 2021 -$3.76M -$1.02M -$142K -16.1% May 1, 2021 Jul 31, 2021 10-Q 2022-09-14
Q1 2021 -$3.62M -$1.03M -$285K -38% Feb 1, 2021 Apr 30, 2021 10-K 2022-07-28
Q4 2020 -$3.34M -$757K +$118K +13.5% Nov 1, 2020 Jan 31, 2021 10-Q 2022-03-15
Q3 2020 -$3.46M -$950K +$118K +11% Aug 1, 2020 Oct 31, 2020 10-Q 2021-12-14
Q2 2020 -$3.57M -$882K +$252K +22.3% May 1, 2020 Jul 31, 2020 10-Q 2021-09-14
Q1 2020 -$3.83M -$750K +$422K +36% Feb 1, 2020 Apr 30, 2020 10-K 2021-08-10
Q4 2019 -$4.25M -$875K -$199K -29.4% Nov 1, 2019 Jan 31, 2020 10-Q 2021-03-12
Q3 2019 -$4.05M -$1.07M -$30.5K -2.95% Aug 1, 2019 Oct 31, 2019 10-Q 2020-12-11
Q2 2019 -$4.02M -$1.13M +$81.3K +6.69% May 1, 2019 Jul 31, 2019 10-Q 2020-09-11
Q1 2019 -$4.1M -$1.17M +$276K +19% Feb 1, 2019 Apr 30, 2019 10-K 2020-08-13
Q4 2018 -$4.38M -$676K +$1.35M +66.7% Nov 1, 2018 Jan 31, 2019 10-Q 2020-03-13
Q3 2018 -$5.73M -$1.04M +$778K +42.9% Aug 1, 2018 Oct 31, 2018 10-Q 2019-12-23
Q2 2018 -$6.51M -$1.22M +$473K +28% May 1, 2018 Jul 31, 2018 10-Q 2019-09-13
Q1 2018 -$6.98M -$1.45M -$294K -25.4% Feb 1, 2018 Apr 30, 2018 10-K 2019-08-13
Q4 2017 -$6.69M -$2.03M -$749K -58.4% Nov 1, 2017 Jan 31, 2018 10-Q 2019-03-14
Q3 2017 -$5.94M -$1.81M -$840K -86.2% Aug 1, 2017 Oct 31, 2017 10-Q 2018-12-14
Q2 2017 -$5.1M -$1.69M -$657K -63.7% May 1, 2017 Jul 31, 2017 10-Q 2018-09-12
Q1 2017 -$4.44M -$1.15M -$23.7K -2.1% Feb 1, 2017 Apr 30, 2017 10-K 2018-07-20
Q4 2016 -$4.42M -$1.28M +$510K +28.5% Nov 1, 2016 Jan 31, 2017 10-Q 2018-03-19
Q3 2016 -$4.93M -$974K +$662K +40.4% Aug 1, 2016 Oct 31, 2016 10-Q 2017-12-14
Q2 2016 -$5.59M -$1.03M +$483K +31.9% May 1, 2016 Jul 31, 2016 10-Q 2017-09-13
Q1 2016 -$6.07M -$1.13M +$2.84M +71.6% Feb 1, 2016 Apr 30, 2016 10-K 2017-07-27
Q4 2015 -$8.92M -$1.79M -$336K -23% Nov 1, 2015 Jan 31, 2016 10-Q/A 2017-03-13
Q3 2015 -$8.58M -$1.64M +$4.61M +73.8% Aug 1, 2015 Oct 31, 2015 10-Q 2016-12-02
Q2 2015 -$13.2M -$1.51M +$68.8K +4.35% May 1, 2015 Jul 31, 2015 10-Q 2016-09-06
Q1 2015 -$13.3M -$3.98M +$12.5M +75.8% Feb 1, 2015 Apr 30, 2015 10-K 2016-07-29
Q4 2014 -$25.7M -$1.46M -$775K -114% Nov 1, 2014 Jan 31, 2015 10-Q 2016-03-08
Q3 2014 -$25M -$6.25M -$5.8M -1292% Aug 1, 2014 Oct 31, 2014 10-Q/A 2016-01-19
Q2 2014 -$19.2M -$1.58M -$182K -13% May 1, 2014 Jul 31, 2014 10-Q/A 2016-01-19
Q1 2014 -$19M -$16.4M -$16M -3508% Feb 1, 2014 Apr 30, 2014 10-K 2016-07-29
Q4 2013 -$2.99M -$681K -$340K -99.8% Nov 1, 2013 Jan 31, 2014 10-Q 2015-03-13
Q3 2013 -$2.65M -$449K -$99.8K -28.6% Aug 1, 2013 Oct 31, 2013 10-Q 2014-12-15
Q2 2013 -$2.55M -$1.4M -$862K -160% May 1, 2013 Jul 31, 2013 10-Q 2014-09-15
Q1 2013 -$1.68M -$456K +$26.9K +5.58% Feb 1, 2013 Apr 30, 2013 10-K/A 2016-01-19
Q4 2012 -$1.71M -$341K +$69.1K +16.9% Nov 1, 2012 Jan 31, 2013 10-Q 2014-03-17
Q3 2012 -$1.78M -$349K +$54.9K +13.6% Aug 1, 2012 Oct 31, 2012 10-Q 2013-12-16
Q2 2012 -$1.84M -$539K +$114K +17.4% May 1, 2012 Jul 31, 2012 10-Q 2013-09-16
Q1 2012 -$1.95M -$483K Feb 1, 2012 Apr 30, 2012 10-K 2013-07-29
Q4 2011 -$410K Nov 1, 2011 Jan 31, 2012 10-Q 2013-03-26
Q3 2011 -$404K Aug 1, 2011 Oct 31, 2011 10-Q 2012-12-26
Q2 2011 -$653K May 1, 2011 Jul 31, 2011 10-Q 2012-09-19
* An asterisk sign (*) next to the value indicates that the value is likely invalid.